1,3-Dimethylbutanamine, 1,3-dimethylbutylamine, 1,3-Dimethyl-Butylamine, 1,3-Dimethylbutylamine Citrate, 2-Amino-4-Methylpentane, 4-AMP, 4-Amino-2-Methylpentane Citrate, 4-Amino-2-Pentanamine, 4-Methyl-2-Pentanamine, 4-Methylpentan-2-Amine, AMP citrate, Dimethylbutylamine, DMBA, Methylpentane Citrate.
Methylpentane is a chemical that is similar to the unsafe chemical 1,3-dimethylamylamine (DMAA) that has been banned by the US Food and Drug Administration. It is commonly found in supplements that claim to help people lose weight, improve athletic performance, and improve brain function.
How does it work?
Methylpentane works like a stimulant and is similar to the chemical DMAA. Like DMAA, it can cause blood vessels to contract in some parts of the body and speed up heart rate.
Insufficient Evidence to Rate Effectiveness for...
- Weight loss.
- Athletic performance.
- Other conditions.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Stimulant drugsInteraction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Stimulant drugs can speed up the nervous system and heart. By speeding up the nervous system, stimulant medications can make you feel jittery and speed up your heartbeat. Methylpentane might also speed up the nervous system and heart. Taking methylpentane along with stimulant drugs might cause serious problems such as an increased heart rate. Avoid taking stimulant drugs along with methylpentane.
The appropriate dose of methylpentane depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for methylpentane. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.
Cohen PA, Travis JC, and Venhuis BJ. A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Drug Test Analysis.,10-8-2014.
Farney TM, McCarthy C, Canale RE, et al. Hemodynamic and hematologic profile of health adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine. Nutr Metab Insights 2012;5:1-12.
FDA challenges marketing of DMAA products for lack of safety evidence. US Food and Drug Administration, April 27, 2012. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302133.htm
Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J 2010;123:124-7. View abstract.
Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. View abstract.
Material Safety Data Sheet. 1,3-Dimethylbutylamine, 98%. https://www.fishersci.ca/viewmsds.do?catNo=AC314700050.
McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.
McCarthy C, Farney TM, Canale RE, et al. A finished dietary supplement stimulates lipolysis and metabolic rate in young men and women. Nutr Metab Insights 2012;5:23-31.
Removal of the dietary supplement DMAA. Army Medicine, Office of the Surgeon General, 2011. Available at: http://humanperformanceresourcecenter.org/dietary-supplements/files/dmaa-pdf. (Accessed 4 January 2012).
SWANSON EE, CHEN KK. Comparison of pressor action of alicyclic derivatives of aliphatic amines. J Pharmacol Exp Ther. 1948 Aug;93(4):423-9. View abstract.